S1	O
Previous	O
analysis	O
of	O
data	O
from	O
92	O
families	O
,	O
ascertained	O
through	O
a	O
parent	O
with	O
asthma	O
,	O
showed	O
evidence	O
for	O
recessive	BP
inheritance-20	IP
of	O
high	BP
IgE	IP
levels-24	IP
with	O
linkage	O
to	O
chromosome	BG
5q-29	IG
.	O

S4	O
For	O
type	O
1	O
diabetes	O
it	O
is	O
clear	O
that	O
multiple	BG
islet	IG
molecules-11	IG
are	O
the	O
target	O
of	O
autoimmunity-16	BP
in	O
man	O
and	O
animal	O
models	O
1	O
,	O
2	O
.	O

S5	O
It	O
is	O
not	O
clear	O
whether	O
any	O
of	O
the	O
target	BG
molecules-10	IG
are	O
essential	O
for	O
the	O
destruction	BP
of	IP
islet	IP
beta	IP
cells-19	IP
.	O

S6	O
Here	O
we	O
show	O
that	O
the	O
proinsulin	BG
/	IG
insulin	IG
molecules-9	IG
have	O
a	O
sequence	O
that	O
is	O
a	O
primary	O
target	O
of	O
the	O
autoimmunity-20	BP
that	O
causes	O
diabetes	O
of	O
the	O
non	O
-	O
obese	O
diabetic	O
(	O
NOD	O
)	O
mouse	O
.	O

S9	O
The	O
adipocyte	BG
fatty	IG
acid	IG
–binding	IG
protein-6	IG
aP2-7	BG
is	O
required	O
in	O
allergic	BP
airway	IP
airway-13	IP

S10	O
The	O
adipocyte	BG
fatty	IG
acid	IG
–binding	IG
protein-6	IG
aP2-7	BG
regulates	O
systemic	BP
glucose-10	IP
and	O
lipid	BP
metabolism-13	IP
.	O

S11	O
We	O
report	O
that	O
aP2-4	BG
,	O
in	O
addition	O
to	O
being	O
abundantly	O
expressed	O
by	O
adipocytes	O
,	O
is	O
also	O
expressed	O
by	O
human	O
airway	O
epithelial	O
cells	O
and	O
shows	O
a	O
striking	BP
upregulation-27	IP
following	O
stimulation	O
of	O
epithelial	O
cells	O
with	O
the	O
Th2	BG
cytokines-36	IG
IL	BG
-	IG
4-39	IG
and	O
IL	BG
-	IG
13-43	IG
.	O

S12	O
Regulation	BP
of	IP
aP2	IP
mRNA	IP
expression-5	IP
by	O
Th2	BG
cytokines-8	IG
was	O
highly	O
dependent	O
on	O
STAT6-13	BG
,	O
a	O
transcription	BG
factor-17	IG
with	O
a	O
major	O
regulatory	O
role	O
in	O
allergic	BP
inflammation-25	IP
.	O

S14	O
T	BP
cell	IP
priming-3	IP
was	O
unaffected	O
by	O
aP2	BP
deficiency-8	IP
,	O
suggesting	O
that	O
aP2-12	BG
was	O
acting	O
locally	O
within	O
the	O
lung	O
,	O
and	O
analysis	O
of	O
bone	O
marrow	O
chimeras	O
implicated	O
non	O
-	O
hematopoietic	O
cells	O
,	O
most	O
likely	O
bronchial	O
epithelial	O
cells	O
,	O
as	O
the	O
site	O
of	O
action	O
of	O
aP2-44	BG
in	O
allergic	BP
airway	IP
inflammation-48	IP
.	O

S22	O
Here	O
we	O
report	O
the	O
association	O
of	O
RA	BP
susceptibility-8	IP
with	O
the	O
minor	BG
allele-12	IG
of	O
a	O
missense	O
SNP	O
in	O
PTPN22-18	BG
(	O
discovery	O
-	O
study	O
allelic	O
P	O
=	O
6	O
.	O
6	O
×10	O
-	O
4	O
;	O
replication	O
-	O
study	O
allelic	O
P	O
=	O
5	O
.	O
6	O
×10	O
-	O
8	O
)	O
,	O
which	O
encodes	O
a	O
hematopoietic	BG
-	IG
specific	IG
protein	IG
tyrosine	IG
phosphatase-55	IG
also	O
known	O
as	O
“Lyp”-59	BG
.	O

S23	O
We	O
show	O
that	O
the	O
risk	BG
allele-6	IG
,	O
which	O
is	O
present	O
in	O
∼17	O
%	O
of	O
white	O
individuals	O
from	O
the	O
general	O
population	O
and	O
in	O
∼28	O
%	O
of	O
white	O
individuals	O
with	O
RA	O
,	O
disrupts	O
the	O
P1	BG
proline	IG
-	IG
rich	IG
motif-37	IG
that	O
is	O
important	O
for	O
interaction	O
with	O
Csk-44	BG
,	O
potentially	O
altering	O
these	O
proteins-49	BG
'	O
normal	O
function	O
as	O
negative	O
regulators	O
of	O
T	BP
-	IP
cell	IP
activation-60	IP
.	O 

S24	O
IL	O
-	O
23	O
is	O
essential	O
for	O
T	O
cell	O
–mediated	O
colitis	O
and	O
promotes	O
inflammation-13	BP
via	O
IL	BG
-	IG
17-17	IG
and	O
IL	BG
-	IG
--21	IG

S25	O
In	O
early	O
clinical	O
trials	O
as	O
well	O
as	O
in	O
animal	O
models	O
,	O
IL	BG
-	IG
12-14	IG
has	O
been	O
implicated	O
as	O
a	O
major	O
mediator	O
of	O
these	O
diseases	O
based	O
on	O
the	O
ability	O
of	O
anti	O
-	O
p40	O
mAb	O
treatment	O
to	O
reverse	O
intestinal	BP
inflammation-38	IP
.	O

S26	O
To	O
determine	O
how	O
IL	BG
-	IG
23-6	IG
contributes	O
to	O
intestinal	BP
inflammation-10	IP
,	O
we	O
studied	O
the	O
disease	O
susceptibility	O
in	O
the	O
absence	O
of	O
either	O
IL	BG
-	IG
23-24	IG
or	O
IL	BG
-	IG
12-28	IG
in	O
this	O
model	O
,	O
as	O
well	O
as	O
the	O
ability	O
of	O
recombinant	O
IL	BG
-	IG
23-42	IG
to	O
exacerbate	O
IBD	O
induced	O
by	O
T	BP
cell	IP
transfer-50	IP
.	O

S27	O
Our	O
study	O
shows	O
that	O
in	O
these	O
models	O
,	O
IL	BG
-	IG
23-11	IG
is	O
essential	O
for	O
manifestation	O
of	O
chronic	BP
intestinal	IP
inflammation-19	IP
,	O
whereas	O
IL	BG
-	IG
12-24	IG
is	O
not	O
.	O 

S28	O
Systemic	O
lupus	O
erythematosus	O
-	O
associated	O
defects	O
in	O
the	O
inhibitory	BG
receptor-10	IG
FcγRIIb-11	BG
reduce	O
susceptibility	BP
to	IP
malaria	IP
.	O 

S30	O
In	O
vitro	O
,	O
the	O
human	O
lupus	O
associated	O
FcγRIIb-8	BG
polymorphism	O
enhances	O
phagocytosis	BP
of	IP
Plasmodium	IP
falciparum	IP
-	IP
infected	IP
erythrocytes-17	IP
.	O

S31	O
These	O
results	O
demonstrate	O
that	O
FcγRIIb-5	BG
is	O
important	O
in	O
controlling	O
the	O
immune	BP
response	IP
to	IP
malarial	IP
parasites-15	IP
and	O
suggests	O
that	O
the	O
higher	O
frequency	O
of	O
human	BG
FcγRIIb-24	IG
polymorphisms	O
predisposing	O
to	O
SLE	O
in	O
Asians	O
and	O
Africans	O
may	O
be	O
maintained	O
because	O
these	O
variants-38	BG
reduce	O
susceptibility	BP
to	IP
malaria-42	IP
.	O 

S34	O
Finally	O
,	O
10	O
of	O
the	O
regions-6	BG
showing	O
evidence	O
for	O
linkage	O
in	O
the	O
Hutterites	O
have	O
shown	O
evidence	O
of	O
linkage	O
to	O
related	BP
phenotypes-21	IP
in	O
other	O
genome	O
screens	O
,	O
suggesting	O
that	O
these	O
regions-30	BG
may	O
contain	O
common	BG
alleles-34	IG
that	O
have	O
relatively	O
large	O
effects	O
on	O
asthma	BP
and	IP
atopy	IP
phenotypes-44	IP
in	O
diverse	O
populations	O
.	O 

S36	O
An	O
increasing	O
number	O
of	O
studies	O
suggest	O
the	O
importance	O
of	O
antibodies-10	BG
in	O
the	O
pathogenesis-13	BP
of	O
most	O
systemic	O
and	O
organ	O
-	O
specific	O
autoimmune	O
diseases	O
,	O
although	O
there	O
is	O
considerable	O
controversy	O
over	O
the	O
precise	O
role	O
of	O
the	O
autoantibodies-35	BG
involved	O
.	O

S39	O
Although	O
BBS	BG
proteins-3	IG
were	O
not	O
required	O
for	O
ciliogenesis-8	BP
,	O
their	O
loss	O
caused	O
structural	O
defects	O
in	O
a	O
fraction	O
of	O
cilia	O
covering	O
mouse	O
airway	O
epithelia	O
.	O

S43	O
The	O
cytokines	O
B	BG
lymphocyte	IG
stimulator-5	IG
(	O
BLyS-7	BG
)	O
and	O
a	BG
proliferation	IG
-	IG
inducing	IG
ligand-14	IG
(	O
APRIL-16	BG
)	O
enhance	O
autoimmune	O
disease	O
by	O
sustaining	O
B	BP
cell	IP
activation-25	IP
.	O

S49	O
A	O
strong	O
influence	O
of	O
non	BG
-	IG
MHC	IG
genes-8	IG
was	O
also	O
suggested	O
by	O
the	O
variability	O
of	O
arthritis	BP
susceptibility-17	IP
among	O
different	O
strains	O
with	O
the	O
same	O
MHC	BG
haplotype-25	IG
;	O
the	O
most	O
susceptible	O
background	O
was	O
the	O
DA	O
and	O
the	O
least	O
susceptible	O
was	O
the	O
E3	O
.	O 

S57	O
Subjects	O
with	O
the	O
TLR5	BG
stop	IG
codon-6	IG
produced	O
significantly	BP
lower	IP
levels	IP
of	IP
proinflammatory	IP
cytokines-13	IP
in	O
comparison	O
with	O
individuals	O
with	O
the	O
wild	BG
-	IG
type	IG
genotype-23	IG
.	O

S59	O
Systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
is	O
an	O
autoimmune	O
disorder	O
characterized	O
by	O
production	BP
of	IP
autoantibodies	IP
against	IP
intracellular	IP
antigens-18	IP
including	O
DNA-20	BG
,	O
ribosomal	BG
P-23	IG
,	O
Ro-25	BG
(	O
SS	BG
-	IG
A-29	IG
)	O
,	O
La-32	BG
(	O
SS	BG
-	IG
B-36	IG
)	O
,	O
and	O
the	O
spliceosome-41	BG
.	O

S60	O
Evidence	O
of	O
genetic	O
involvement	O
includes	O
:	O
associations	O
with	O
HLA	BG
-	IG
DR3-11	IG
,	O
HLA	BG
-	IG
DR2-15	IG
,	O
Fcγ	BG
receptors	IG
(	IG
FcγR	IG
)	IG
IIA	IG
and	IG
IIIA-24	IG
,	O
and	O
hereditary	BP
complement	IP
component	IP
deficiencies-30	IP
,	O
as	O
well	O
as	O
familial	O
aggregation	O
,	O
monozygotic	O
twin	O
concordance	O
>	O
20	O
%	O
,	O
λ	O
s	O
>	O
10	O
,	O
purported	O
linkage	O
at	O
1q41	BG
–42-54	IG
,	O
and	O
inbred	O
mouse	O
strains	O
that	O
consistently	O
develop	O
lupus	O
.	O 

S61	O
Several	O
of	O
the	O
regions-4	BG
that	O
showed	O
evidence	O
for	O
nominal	O
significance	O
(	O
P	O
<	O
.	O
05	O
)	O
in	O
our	O
data	O
set	O
had	O
previously	O
been	O
implicated	O
in	O
RA	O
(	O
D16S516-28	BG
and	O
D17S1301-30	BG
)	O
or	O
in	O
other	O
diseases	O
of	O
an	O
autoimmune	O
nature	O
,	O
including	O
systemic	BP
lupus	IP
erythematosus	IP
(	O
D1S235-46	BG
)	O
,	O
inflammatory	BP
bowel	IP
disease	IP
(	O
D4S1647-53	BG
,	O
D5S1462-55	BG
,	O
and	O
D16S516-58	BG
)	O
,	O
multiple	BP
sclerosis	IP
(	O
D12S1052-64	BG
)	O
,	O
and	O
ankylosing	BP
spondylitis	IP
(	O
D16S516-71	BG
)	O
.	O

S63	O
We	O
investigated	O
the	O
interactions	O
between	O
day	O
care	O
exposure	O
in	O
the	O
1st	O
6	O
month	O
of	O
life	O
and	O
genotypes	O
for	O
72	BG
polymorphisms	IG
at	O
45	O
candidate	O
loci	O
and	O
their	O
effects	O
on	O
cytokine	BP
response	IP
profiles-31	IP
and	O
on	O
the	O
development	O
of	O
atopic	BP
phenotypes-38	IP
in	O
the	O
1st	O
year	O
of	O
life	O
in	O
the	O
Childhood	O
Onset	O
of	O
Asthma	O
(	O
COAST	O
)	O
cohort	O
of	O
children	O
.	O

S65	O
Genome	O
-	O
wide	O
linkage	O
searches	O
of	O
autoimmune	O
and	O
inflammatory	O
/	O
immune	O
disorders	O
have	O
identified	O
a	O
large	O
number	O
of	O
non	BG
-	IG
major	IG
histocompatibility	IG
complex	IG
loci-24	IG
that	O
collectively	O
contribute	O
to	O
disease	BP
susceptibility-30	IP
.	O 

S66	O
Except	O
for	O
rare	O
,	O
high	O
-	O
penetrance	O
syndromes	O
showing	O
Mendelian	BP
inheritance-11	IP
,	O
such	O
as	O
BRCA1-15	BG
and	O
BRCA2-17	BG
,	O
most	O
attempts	O
have	O
failed	O
to	O
produce	O
replicable	O
linkage	O
findings	O
.	O

S67	O
Despite	O
failure	O
to	O
replicate	O
the	O
previous	O
evidence	O
for	O
linkage	O
on	O
chromosome	BG
12	IG
,	O
the	O
results	O
described	O
herein	O
indicate	O
the	O
need	O
to	O
further	O
investigate	O
the	O
potential	O
role	O
of	O
this	O
locus	O
in	O
susceptibility	BP
to	IP
ulcerative	IP
colitis-34	IP
.	O 

S68	O
Among	O
the	O
glycoprotein	O
hormone	O
receptors	O
,	O
only	O
the	O
TSHR-9	BG
undergoes	O
intramolecular	BP
cleavage-12	IP
into	O
disulfide	O
-	O
linked	O
subunits	O
with	O
consequent	O
shedding-20	BP
of	O
some	O
of	O
the	O
extracellular	O
,	O
autoantibody	O
-	O
binding	O
A	BG
subunits-31	IG
.	O

S70	O
SLE	O
like	O
syndrome	O
and	O
functional	BP
deficiency-6	IP
of	O
C1q-8	BG
in	O
members	O
of	O
a	O
large	O
family	O
.	O  

S73	O
Genetic	O
linkage	O
of	O
familial	O
granulomatous	O
inflammatory	O
arthritis	O
,	O
skin	BP
rash-10	IP
,	O
and	O
uveitis	O
to	O
chromosome	BG
16-16	IG
.	O

S76	O
The	O
best	O
-	O
fitting	O
model	O
of	O
shared	O
components	O
of	O
variance	O
indicated	O
that	O
8	O
%	O
of	O
the	O
genetic	BG
component-18	IG
of	O
obesity-20	BP
is	O
shared	O
with	O
asthma	O
.	O

S79	O
To	O
explore	O
its	O
role	O
in	O
human	O
disease	O
,	O
we	O
analyzed	O
1	O
,	O
416	O
individuals	O
from	O
258	O
Caucasian	O
and	O
142	O
Chinese	O
lupus	O
simplex	O
families	O
and	O
demonstrated	O
that	O
a	O
common	O
three	BG
-	IG
single	IG
-	IG
nucleotide	IG
polymorphism	IG
CR2	BG
haplotype-36	IG
(	O
rs3813946	O
,	O
rs1048971	O
,	O
rs17615	O
)	O
was	O
associated	O
with	O
lupus	BP
susceptibility-48	IP
(	O
P	O
=	O
0	O
.	O
00001	O
)	O
with	O
a	O
1	O
.	O
54	O
-	O
fold	O
increased	O
risk	O
for	O
the	O
development	O
of	O
disease	O
.	O

S85	O
Linkage	O
of	O
asthma	BP
and	IP
related	IP
phenotypes-6	IP
to	O
chromosome	BG
6p21-9	IG
has	O
been	O
reported	O
in	O
seven	O
genome	O
screens	O
,	O
making	O
it	O
the	O
most	O
replicated	O
region-23	BG
of	O
the	O
genome	O
.	O 

S87	O
Interindividual	O
gene-2	BG
copy	O
-	O
number	O
variation	O
(	O
CNV	O
)	O
of	O
complement	BG
component	IG
C4-13	IG
and	O
its	O
associated	O
polymorphisms	O
in	O
gene-19	BG
size	O
(	O
long	O
and	O
short	O
)	O
and	O
protein	BG
isotypes-28	IG
(	O
C4A-30	BG
and	O
C4B-32	BG
)	O
probably	O
lead	O
to	O
different	O
susceptibilities	BP
to	IP
autoimmune	IP
disease-41	IP
.	O

S88	O
The	O
risk	O
of	O
SLE	BP
disease	IP
susceptibility-6	IP
significantly	O
increased	O
among	O
subjects	O
with	O
only	O
two	O
copies	O
of	O
total	O
C4-17	BG
(	O
patients	O
9	O
.	O
3	O
%	O
;	O
unrelated	O
controls	O
1	O
.	O
5	O
%	O
;	O
odds	O
ratio	O
[	O
OR	O
]	O
=	O
6	O
.	O
514	O
;	O
P	O
=	O
.	O
00002	O
)	O
but	O
decreased	O
in	O
those	O
with	O
5	O
copies	O
of	O
C4-55	BG
(	O
patients	O
5	O
.	O
79	O
%	O
;	O
controls	O
12	O
%	O
;	O
OR	O
=	O
0	O
.	O
466	O
;	O
P	O
=	O
.	O
016	O
)	O
.	O

S91	O
TYK2-1	BG
binds	O
to	O
the	O
type	BG
I	IG
IFN	IG
receptor	IG
complex-9	IG
and	O
IRF5-11	BG
is	O
a	O
regulator	O
of	O
type	BP
I	IP
IFN	IP
gene	IP
expression-20	IP
.	O 

S95	O
Furthermore	O
,	O
ICOS-3	BG
regulates	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
expression	BP
of	IP
IL	IP
-	IP
17-15	IP
,	O
a	O
proinflammatory	O
cytokine	O
implicated	O
in	O
rheumatoid	O
arthritis	O
.	O 

S97	O
The	O
2p25	BG
.	IG
1	IG
region-5	IG
was	O
detected	O
for	O
the	O
FCHL	BP
trait-11	IP
,	O
and	O
the	O
9p23-15	BG
and	O
16q24	BG
.	IG
1	IG
regions-20	IG
were	O
detected	O
for	O
the	O
low	BP
high	IP
-	IP
density	IP
lipoprotein	IP
cholesterol	IP
(	IP
HDL	IP
-	IP
C	IP
)	IP
trait-36	IP
.	O

S100	O
Apart	O
from	O
rare	BP
monogenic	IP
deficiencies-5	IP
of	O
complement	BG
factors-8	IG
,	O
where	O
lupuslike	O
disease	O
may	O
occur	O
in	O
association	O
with	O
other	O
autoimmune	O
diseases	O
or	O
high	BP
susceptibility	IP
to	IP
bacterial	IP
infections-26	IP
,	O
its	O
etiology	O
is	O
multifactorial	O
in	O
nature	O
.	O

S103	O
Systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
is	O
an	O
autoimmune	O
disease	O
characterized	O
by	O
a	O
loss	BP
of	IP
immunologic	IP
tolerance-17	IP
to	O
a	O
multitude	O
of	O
self	BG
-	IG
antigens-24	IG
.	O

S104	O
Epidemiological	O
data	O
suggest	O
an	O
important	O
role	O
for	O
genes	O
in	O
the	O
etiology	O
of	O
lupus	O
,	O
and	O
previous	O
genetic	O
studies	O
have	O
implicated	O
the	O
HLA	BG
locus-23	IG
,	O
complement	BG
genes-26	IG
,	O
and	O
low	BG
-	IG
affinity	IG
IgG	IG
(	IG
Fcγ	IG
)	IG
receptors-36	IG
in	O
SLE	BP
pathogenesis-39	IP
.	O 

S105	O
The	O
nuclear	O
receptors	O
DAX1-4	BG
(	O
NR0B1-6	BG
)	O
and	O
steroidogenic	BG
factor	IG
-	IG
1-12	IG
(	O
SF1-14	BG
/	O
Ad4BP-16	BG
,	O
NR5A1-18	BG
)	O
play	O
an	O
important	O
role	O
in	O
adrenal	BP
development-26	IP
and	O
function	O
,	O
and	O
mutations	O
in	O
these	O
transcription	O
factors	O
have	O
been	O
found	O
in	O
patients	O
with	O
adrenal	O
hypoplasia	O
.	O

S106	O
SF1	BG
mutations-2	IG
causing	O
adrenal	O
failure	O
were	O
found	O
only	O
in	O
two	O
patients	O
with	O
46	BP
,	IP
XY	IP
gonadal	IP
dysgenesis-17	IP
.	O

S107	O
Thus	O
,	O
this	O
segment-4	BG
of	O
the	O
genome	O
represents	O
a	O
candidate	BG
region-11	IG
for	O
genes	O
that	O
determine	O
susceptibility	BP
to	IP
bronchial	IP
hyperresponsiveness	IP
and	IP
atopy-21	IP
in	O
animal	O
models	O
.	O

S109	O
The	O
expression	BP
of	IP
IL	IP
-	IP
9-6	IP
was	O
markedly	O
reduced	O
in	O
bronchial	O
hyporesponsive	O
mice	O
,	O
and	O
the	O
level	O
of	O
expression	O
was	O
determined	O
by	O
sequences	O
within	O
the	O
qualitative	BG
trait	IG
locus-28	IG
(	O
QTL-30	BG
)	O
.	O

S114	O
In	O
conclusion	O
,	O
a	O
lower	O
HBD	BG
-	IG
2	IG
gene-9	IG
copy	O
number	O
in	O
the	O
beta	O
-	O
defensin	O
locus	O
predisposes	O
to	O
colonic	O
CD	O
,	O
most	O
likely	O
through	O
diminished	BP
beta	IP
-	IP
defensin	IP
expression-30	IP
.	O 

S121	O
Our	O
original	O
association	O
study	O
focused	O
on	O
the	O
role	O
of	O
IBD5-10	BG
in	O
CD	O
;	O
we	O
next	O
explored	O
the	O
potential	O
contribution	O
of	O
this	O
locus-22	BG
to	O
UC	BP
susceptibility-25	IP
in	O
187	O
German	O
trios	O
.	O 

S128	O
CARD15-1	BG
conferred	O
susceptibility	BP
to	IP
PsA-5	IP
independent	O
of	O
HLA	BG
-	IG
Cw	IG
*	IG
0602-12	IG
.	O 

S134	O
These	O
results	O
suggest	O
that	O
several	O
major	BG
genes-7	IG
,	O
plus	O
residual	O
genetic	O
effects	O
,	O
regulate	O
total	BP
serum	IP
IgE	IP
levels-18	IP
.	O 

S137	O
Identification	O
of	O
these	O
molecular	BG
targets-5	IG
provides	O
insight	O
into	O
the	O
pathogenic	BP
process-11	IP
,	O
diagnostic	O
assays	O
,	O
and	O
potential	O
therapeutic	O
agents	O
.	O

S140	O
The	O
combined	O
measurement	O
of	O
ZnT8A-5	BG
,	O
GADA-7	BG
,	O
IA2A-9	BG
,	O
and	O
IAA-12	BG
raised	O
autoimmunity-14	BP
detection	O
rates	O
to	O
98	O
%	O
at	O
disease	O
onset	O
,	O
a	O
level	O
that	O
approaches	O
that	O
needed	O
to	O
detect	O
prediabetes	O
in	O
a	O
general	O
pediatric	O
population	O
.	O 

S143	O
Using	O
the	O
family	O
-	O
based	O
association	O
test	O
(	O
FBAT	O
)	O
program	O
and	O
its	O
haplotype-14	BG
(	O
HBAT	O
)	O
and	O
phenotype	O
(	O
PBAT	O
)	O
options	O
,	O
we	O
tested	O
each	O
polymorphism	O
and	O
haplotype-30	BG
for	O
association	O
with	O
asthma	O
and	O
asthma	BP
-	IP
related	IP
phenotypes-39	IP
.	O

S147	O
We	O
have	O
used	O
a	O
mouse	O
model	O
for	O
asthma	O
to	O
determine	O
the	O
effect	O
of	O
PI3K	O
inhibitors	O
and	O
PTEN-17	BG
on	O
allergen	BP
-	IP
induced	IP
bronchial	IP
inflammation-23	IP
and	O
airway	O
hyperresponsiveness	O
.	O

S153	O
However	O
,	O
we	O
cannot	O
yet	O
exclude	O
a	O
primary	O
role	O
for	O
DQA1-11	BG
or	O
for	O
other	O
polymorphisms	O
that	O
affect	O
DRB1	BP
function	IP
or	IP
expression-21	IP
.	O 

S155	O
This	O
region	O
of	O
15q21-4	BG
also	O
harbors	O
the	O
gene	O
for	O
SPPL2A-10	BG
(	O
signal	BG
peptide	IG
peptidase	IG
like	IG
2a-16	IG
)	O
which	O
activates	O
tumor	BG
necrosis	IG
factor	IG
alpha-23	IG
by	O
cleavage	O
,	O
triggering	O
the	O
expression	BP
of	IP
IL12-31	IP
in	O
human	O
dendritic	O
cells	O
.	O 

S156	O
The	O
Intestinal	BP
T	IP
Cell	IP
Response-5	IP
to	O
α	O
-	O
Gliadin	O
in	O
Adult	O
Celiac	O
Disease	O
Is	O
Focused	O
on	O
a	O
Single	BG
Deamidated	IG
Glutamine-20	IG
Targeted	O
by	O
Tissue	BG
transglutaminase	IG
.	O

S158	O
Interestingly	O
,	O
tissue	BP
transglutaminase	IP
(	IP
tTG	IP
)	IP
-	IP
mediated	IP
deamidation-10	IP
of	O
gliadin-12	BG
plays	O
an	O
important	O
role	O
in	O
recognition	BP
of	IP
this	IP
food	IP
antigen-22	IP
by	O
intestinal	O
T	O
cells	O
.	O

S159	O
Here	O
we	O
have	O
used	O
recombinant	BG
antigens-6	IG
to	O
demonstrate	O
that	O
the	O
intestinal	BP
T	IP
cell	IP
response	IP
to	IP
α	IP
-	IP
gliadin-18	IP
in	O
adult	O
CD	O
is	O
focused	O
on	O
two	O
immunodominant	BG
,	IG
DQ2	IG
-	IG
restricted	IG
peptides-31	IG
that	O
overlap	O
by	O
a	O
seven	BG
-	IG
residue	IG
fragment-39	IG
of	O
gliadin	O
.	O

S162	O
These	O
results	O
suggest	O
modifications	BP
of	IP
anchor	IP
residues-7	IP
that	O
lead	O
to	O
an	O
improved	O
affinity	O
for	O
major	BG
histocompatibility	IG
complex-17	IG
(	O
MHC-19	BG
)	O
,	O
and	O
altered	O
conformation	O
of	O
the	O
peptide	BG
–MHC	IG
complex-29	IG
may	O
be	O
a	O
critical	O
factor	O
leading	O
to	O
T	BP
cell	IP
responses	IP
to	IP
gliadin-41	IP
and	O
the	O
oral	BP
intolerance	IP
of	IP
gluten-47	IP
found	O
in	O
CD	O
.	O 

S163	O
We	O
analyzed	O
the	O
entire	O
protein	BG
-	IG
coding	IG
sequence	IG
of	O
this	O
gene	O
by	O
reverse	O
-	O
transcription	O
PCR	O
,	O
SSCP	O
,	O
and	O
DNA	O
sequencing	O
in	O
five	O
patients	O
with	O
different	O
clinical	O
expression	O
of	O
X	O
-	O
ALD	O
and	O
in	O
their	O
female	O
relatives	O
;	O
these	O
clinical	O
expressions	O
were	O
cerebral	O
childhood	O
ALD	O
,	O
adrenomyeloneuropathy	O
(	O
AMN	O
)	O
,	O
and	O
"	BP
Addison	IP
disease	IP
only	IP
"	IP
(	IP
ADO	IP
)	IP
phenotype	IP
.	O

S166	O
The	O
disruptive	O
nature	O
of	O
two	O
mutations	O
(	O
i	O
.	O
e	O
.	O
,	O
the	O
frameshift	O
and	O
the	O
nonsense	O
mutation	O
)	O
in	O
patients	O
with	O
biochemically	O
proved	O
childhood	O
ALD	O
and	O
AMN	O
further	O
strongly	O
supports	O
the	O
hypothesis	O
that	O
alterations	O
in	O
this	O
gene-38	BG
play	O
a	O
crucial	O
role	O
in	O
the	O
pathogenesis	BP
of	IP
X	IP
-	IP
ALD-49	IP
.	O 

S174	O
Our	O
results	O
indicate	O
that	O
lupus	O
patients	O
have	O
circulating	O
anti	BG
-	IG
NMDAR	IG
Abs-12	IG
capable	O
of	O
causing	O
neuronal	BP
damage-17	IP
and	O
memory	BP
deficit-20	IP
,	O
if	O
they	O
breach	O
the	O
BBB	O
,	O
and	O
that	O
the	O
Abs-31	BG
exist	O
within	O
patients	O
'	O
brains	O
.	O 

S179	O
In	O
an	O
application	O
to	O
asthma	O
case	O
-	O
control	O
data	O
from	O
the	O
Children	O
’s	O
Health	O
Study	O
,	O
FITF	O
identified	O
a	O
significant	O
multilocus	BG
effect-22	IG
between	O
the	O
nicotinamide	BG
adenine	IG
dinucleotide	IG
(	IG
phosphate	IG
)	IG
reduced	IG
:	IG
quinone	IG
oxidoreductase	IG
gene-35	IG
(	O
NQO1-37	BG
)	O
,	O
myeloperoxidase	BG
gene-41	IG
(	O
MPO-43	BG
)	O
,	O
and	O
catalase	BG
gene-48	IG
(	O
CAT-50	BG
)	O
(	O
unadjusted	O
P	O
=	O
.	O
00026	O
)	O
,	O
three	O
genes	BG
that-62	IG
are	O
involved	O
in	O
the	O
oxidative	BP
stress	IP
pathway-69	IP
.	O  

S182	O
Several	O
quantitative	BP
traits-3	IP
associated	O
with	O
the	O
asthma	BP
phenotype-8	IP
have	O
been	O
linked	O
to	O
markers-13	BG
on	O
chromosome	BG
11q13-16	IG
,	O
although	O
the	O
gene-20	BG
responsible	O
has	O
yet	O
to	O
be	O
well	O
established	O
.	O

S183	O
The	O
gene-2	BG
for	O
Clara	BG
cell	IG
secretory	IG
protein-7	IG
(	O
CC16-9	BG
)	O
is	O
an	O
ideal	O
candidate	O
for	O
involvement	O
in	O
an	O
inherited	O
predisposition	O
to	O
asthma	O
because	O
of	O
its	O
chromosomal	O
location	O
,	O
the	O
role	O
of	O
the	O
CC16	BG
protein-34	IG
in	O
controlling	O
airway	BP
inflammation-38	IP
,	O
and	O
differences	O
in	O
levels	O
of	O
the	O
protein	O
between	O
asthmatics	O
and	O
healthy	O
controls	O
.	O  

S185	O
Autoantibodies-1	BG
directed	O
against	O
citrulline	BG
-	IG
containing	IG
proteins-7	IG
have	O
an	O
impressive	O
specificity	O
of	O
nearly	O
100	O
%	O
in	O
patients	O
with	O
rheumatoid	O
arthritis	O
and	O
have	O
been	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
disease	BP
pathogenesis-31	IP
.	O

S186	O
The	O
targeted	O
epitopes-3	BG
are	O
generated	O
by	O
a	O
post	BP
-	IP
translational	IP
modification-11	IP
catalysed	O
by	O
the	O
calcium	BG
-	IG
dependent	IG
enzyme	IG
peptidyl	IG
arginine	IG
deiminase-21	IG
(	O
PAD-23	BG
)	O
,	O
which	O
converts	O
positively	O
charged	O
arginine-30	BG
to	O
polar	O
but	O
uncharged	O
citrulline-35	BG
.	O

S187	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
explore	O
the	O
effects	O
of	O
citrullination-12	BP
on	O
the	O
immunogenicity	O
of	O
autoantigens-17	BG
as	O
well	O
as	O
on	O
potential	O
arthritogenicity	O
.	O

S189	O
Our	O
results	O
demonstrate	O
that	O
citrullination	O
of	O
the	O
endogenous	BG
antigen-9	IG
RSA-10	BG
broke	O
immunological	BP
tolerance-13	IP
,	O
as	O
was	O
evident	O
by	O
the	O
generation	O
of	O
antibodies	O
directed	O
against	O
the	O
modified	O
protein	O
and	O
cross	O
-	O
reacting	O
with	O
the	O
native	O
protein	O
.	O

S190	O
In	O
conclusion	O
,	O
our	O
data	O
reveal	O
the	O
potency	O
of	O
citrullination-10	BP
to	O
break	O
tolerance	BP
against	IP
the	IP
self	IP
antigen	IP
RSA-18	IP
and	O
to	O
increase	O
the	O
arthritogenic	O
properties	O
of	O
the	O
cartilage	BG
antigen	IG
CII-29	IG
.	O

S197	O
We	O
performed	O
linkage	O
and	O
association	O
analyses	O
by	O
transmission	O
/	O
disequilibrium	O
test	O
and	O
case	O
-	O
control	O
analysis	O
in	O
the	O
candidate	BG
region-20	IG
12q13	BG
-	IG
24-23	IG
,	O
using	O
the	O
Sardinian	O
founder	O
population	O
,	O
in	O
which	O
limited	O
heterogeneity	O
of	O
pathogenetic	BG
alleles-37	IG
for	O
monogenic	O
and	O
complex	O
disorders	O
as	O
well	O
as	O
of	O
environmental	O
conditions	O
should	O
facilitate	O
the	O
study	O
of	O
multifactorial	BP
traits-55	IP
.	O

S200	O
IRAK	BG
-	IG
M-3	IG
,	O
a	O
negative	O
regulator	O
of	O
the	O
Toll	O
-	O
like	O
receptor	O
/	O
IL	O
-	O
1R	O
pathways	O
,	O
is	O
a	O
master	O
regulator	O
of	O
NF	BG
-	IG
κB-27	IG
and	O
inflammation-29	BP
.	O

S202	O
The	O
Ala893	BG
variant-3	IG
has	O
decreased	O
activity	O
compared	O
with	O
the	O
893Ser	BG
variant-11	IG
;	O
therefore	O
,	O
the	O
association	O
with	O
human	O
IBD	O
is	O
consistent	O
with	O
the	O
murine	O
model	O
of	O
mdr1	BP
deficiency-28	IP
.	O 

